[1]
|
Lewington, S., Clarke, R., Qizilbash, N., et al., Prospective Studies Collaboration (2002) Age-Specific Relevance of Usual Blood Pressure to Vascular Mortality: A Meta-Analysis of Individual Data for One Million Adults in 61 Prospective Studies. The Lancet, 360, 1903-1913. https://doi.org/10.1016/S0140-6736(02)11911-8
|
[2]
|
Leon, B.M. and Maddox, T.M. (2015) Diabetes and Cardiovascular Disease: Epidemiology, Biological Mechanisms, Treatment Recommendations and Future Research. World Journal of Diabetes, 6, 1246-1258. https://doi.org/10.4239/wjd.v6.i13.1246
|
[3]
|
Jung, E., Kong, S.Y., Ro, Y.S., et al. (2022) Serum Cholesterol Levels and Risk of Cardiovascular Death: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies. International Journal of Environmental Research and Public Health, 19, Article 8272. https://doi.org/10.3390/ijerph19148272
|
[4]
|
Tavakoly, A.A., Sany, S.B., Ghayour-Mobarhan, M., et al. (2018) Serum C-Reactive Protein in the Prediction of Cardiovascular Diseases: Overview of the Latest Clinical Studies and Public Health Practice. Journal of Cellular Physiology, 233, 8508-8525. https://doi.org/10.1002/jcp.26791
|
[5]
|
刘俊田. 动脉粥样硬化发病的炎症机制的研究进展[J]. 西安交通大学学报(医学版), 2015(2): 141-152.
|
[6]
|
Libby, P. (2021) The Changing Landscape of Atherosclerosis. Nature, 592, 524-533. https://doi.org/10.1038/s41586-021-03392-8
|
[7]
|
Ray, A., Tatter, S.B., Santhanam, U., et al. (1989) Regulation of Expression of Interleukin-6. Molecular and Clinical Studies. Annals of the New York Academy of Sciences, 557, 353-362. https://doi.org/10.1111/j.1749-6632.1989.tb24028.x
|
[8]
|
Lesina, M., Wörmann, S.M., Neuhöfer, P., et al. (2014) Interleukin-6 in Inflammatory and Malignant Diseases of the Pancreas. Seminars in Immunology, 26, 80-87. https://doi.org/10.1016/j.smim.2014.01.002
|
[9]
|
Tripodi, A. (2011) D-Dimer Testing in Laboratory Practice. Clinical Chemistry, 57, 1256-1262. https://doi.org/10.1373/clinchem.2011.166249
|
[10]
|
Johnson, E.D., Schell, J.C. and Rodgers, G.M. (2019) The D-Dimer Assay. American Journal of Hematology, 94, 833-839. https://doi.org/10.1002/ajh.25482
|
[11]
|
Weitz, J.I., Fredenburgh, J.C. and Eikelboom, J.W. (2017) A Test in Context: D-Dimer. Journal of the American College of Cardiology, 70, 2411-2420. https://doi.org/10.1016/j.jacc.2017.09.024
|
[12]
|
Simes, J., Robledo, K.P., White, H.D., et al. (2018) D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients with Stable Coronary Heart Disease. Circulation, 138, 712-723. https://doi.org/10.1161/CIRCULATIONAHA.117.029901
|
[13]
|
Kyrle, P.A. and Eichinger, S. (2018) D-Dimer for Long-Term Risk Prediction in Patients after Acute Coronary Syndrome. Circulation, 138, 724-726. https://doi.org/10.1161/CIRCULATIONAHA.118.033670
|
[14]
|
Seino, Y., Ikeda, U., Ikeda, M., et al. (1994) Interleukin 6 Gene Transcripts Are Expressed in Human Atherosclerotic Lesions. Cytokine, 6, 87-91. https://doi.org/10.1016/1043-4666(94)90013-2
|
[15]
|
Recinos, A., LeJeune, W.S., Sun, H., et al. (2007) Angiotensin II Induces IL-6 Expression and the Jak-STAT3 Pathway in Aortic Adventitia of LDL Receptor-Deficient Mice. Atherosclerosis, 194, 125-133. https://doi.org/10.1016/j.atherosclerosis.2006.10.013
|
[16]
|
Ishibashi, T., Kimura, H., Shikama, Y., et al. (1989) Interleukin-6 Is a Potent Thrombopoietic Factor in Vivo in Mice. Blood, 74, 1241-1244. https://doi.org/10.1182/blood.V74.4.1241.1241
|
[17]
|
Neumann, F.J., Ott, I., Marx, N., et al. (1997) Effect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant Activity. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 3399-3405. https://doi.org/10.1161/01.ATV.17.12.3399
|
[18]
|
Schuett, H., Luchtefeld, M., Grothusen, C., et al. (2009) How Much Is Too Much? Interleukin-6 and Its Signalling in Atherosclerosis. Thrombosis and Haemostasis, 102, 215-222. https://doi.org/10.1160/TH09-05-0297
|
[19]
|
Hägg, D., Sjöberg, S., Hultén, L.M., et al. (2007) Augmented Levels of CD44 in Macrophages from Atherosclerotic Subjects: A Possible IL-6-CD44 Feedback Loop? Atherosclerosis, 190, 291-297. https://doi.org/10.1016/j.atherosclerosis.2006.03.020
|
[20]
|
Krettek, A., Sukhova, G.K., Schönbeck, U., et al. (2004) Enhanced Expression of CD44 Variants in Human Atheroma and Abdominal Aortic Aneurysm: Possible Role for a Feedback Loop in Endothelial Cells. The American Journal of Pathology, 165, 1571-1581. https://doi.org/10.1016/S0002-9440(10)63414-1
|
[21]
|
Ikeda, U., Ito, T. and Shimada, K. (2001) Interleukin-6 and Acute Coronary Syndrome. Clinical Cardiology, 24, 701-704. https://doi.org/10.1002/clc.4960241103
|
[22]
|
Yamauchi-Takihara, K., Ihara, Y., Ogata, A., et al. (1995) Hypoxic Stress Induces Cardiac Myocyte-Derived Interleukin-6. Circulation, 91, 1520-1524. https://doi.org/10.1161/01.CIR.91.5.1520
|
[23]
|
Lee, K.W., Lip, G.Y., Tayebjee, M., et al. (2005) Circulating Endothelial Cells, Von Willebrand Factor, Interleukin-6, and Prognosis in Patients with Acute Coronary Syndromes. Blood, 105, 526-532. https://doi.org/10.1182/blood-2004-03-1106
|
[24]
|
Reichert, S., Schlitt, A., Benten, A.C., et al. (2016) Data on IL-6 c.-174 G>C Genotype and Allele Frequencies in Patients with Coronary Heart Disease in Dependence of Cardiovascular Outcome. Data in Brief, 8, 1295-1299. https://doi.org/10.1016/j.dib.2016.07.020
|
[25]
|
Rodondi, N., Marques-Vidal, P., Butler, J., et al. (2010) Markers of Atherosclerosis and Inflammation for Prediction of Coronary Heart Disease in Older Adults. American Journal of Epidemiology, 171, 540-549. https://doi.org/10.1093/aje/kwp428
|
[26]
|
刘晓柳, 李光千. 白介素-6及其受体与心血管系统的研究进展[J]. 细胞与分子免疫学杂志, 2009, 25(2): 189-191.
|
[27]
|
Biasucci, L.M., Vitelli, A., Liuzzo, G., et al. (1996) Elevated Levels of Interleukin-6 in Unstable Angina. Circulation, 94, 874-877. https://doi.org/10.1161/01.CIR.94.5.874
|
[28]
|
Batra, G., Lakic, T.G., Lindbäck, J., et al. (2021) Interleukin 6 and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Chronic Coronary Syndrome. JAMA Cardiology, 6, 1440-1445. https://doi.org/10.1001/jamacardio.2021.3079
|
[29]
|
Sanders, J., Hawe, E., Brull, D.J., et al. (2009) Higher IL-6 Levels but not IL6-174G>C or-572G>C Genotype Are Associated with Post-Operative Complication Following Coronary Artery Bypass Graft (CABG) Surgery. Atherosclerosis, 204, 196-201. https://doi.org/10.1016/j.atherosclerosis.2008.08.032
|
[30]
|
Ikeda, U. (2003) Inflammation and Coronary Artery Disease. Current Vascular Pharmacology, 1, 65-70. https://doi.org/10.2174/1570161033386727
|
[31]
|
林小梅, 祖姆热提∙阿布都克依木, 马春晖, 等. 血清白介素6、空腹血糖水平与冠心病及不良心血管事件关系的研究[J]. 中国全科医学, 2024, 27(3): 286-292.
|
[32]
|
Adam, S.S., Key, N.S. and Greenberg, C.S. (2009) D-Dimer Antigen: Current Concepts and Future Prospects. Blood, 113, 2878-2887. https://doi.org/10.1182/blood-2008-06-165845
|
[33]
|
Hoeprich Jr., P.D. and Doolittle, R.F. (1983) Dimeric Half-Molecules of Human Fibrinogen Are Joined through Disulfide Bonds in an Antiparallel Orientation. Biochemistry, 22, 2049-2055. https://doi.org/10.1021/bi00278a003
|
[34]
|
Mosesson, M.W., Siebenlist, K.R., Hainfeld, J.F., et al. (1995) The Covalent Structure of Factor XIIIa Crosslinked Fibrinogen Fibril. Journal of Structural Biology, 115, 88-101. https://doi.org/10.1006/jsbi.1995.1033
|
[35]
|
Longstaff, C. and Kolev, K. (2015) Basic Mechanisms and Regulation of Fibrinolysis. Journal of Thrombosis and Haemostasis, 13, S98-S105. https://doi.org/10.1111/jth.12935
|
[36]
|
庄德荣, 何胜虎, 蔡定华, 等. hs-CRP、D-二聚体和Lp-PLA2与冠心病患者冠状动脉粥样硬化易损斑块的相关性[J]. 现代生物医学进展, 2017, 17(26): 5131-5133.
|
[37]
|
Kothari, H., Nguyen, A.T., Yang, X., et al. (2018) Association of D-Dimer with Plaque Characteristics and Plasma Biomarkers of Oxidation-Specific Epitopes in Stable Subjects with Coronary Artery Disease. Journal of Cardiovascular Translational Research, 11, 221-229. https://doi.org/10.1007/s12265-018-9790-4
|
[38]
|
Soomro, A.Y., Guerchicoff, A., Nichols, D.J., et al. (2016) The Current Role and Future Prospects of D-Dimer Biomarker. European Heart Journal-Cardiovascular Pharmacotherapy, 2, 175-184. https://doi.org/10.1093/ehjcvp/pvv039
|
[39]
|
任爱平, 杨叶, 叶阳. 不稳定型心绞痛患者凝血纤溶指标的变化[J]. 西部医学, 2007, 19(5): 791-792.
|
[40]
|
Tokita, Y., Kusama, Y., Kodani, E., et al. (2009) Utility of Rapid D-Dimer Measurement for Screening of Acute Cardiovascular Disease in the Emergency Setting. Journal of Cardiology, 53, 334-340. https://doi.org/10.1016/j.jjcc.2008.12.001
|
[41]
|
Patil, S.M., Bankar, M.P., Padalkar, R.K., et al. (2014) Study of Plasma Fibrin D-Dimer as Marker of Fibrinolysis and High Sensitive C-Reactive Protein (hs-CRP) as Potential Inflammatory Marker in Acute Stage of Coronary Heart Diseases. Journal of Indian College of Cardiology, 4, 8-13. https://doi.org/10.1016/j.jicc.2014.01.005
|
[42]
|
Gong, X., Lei, X., Huang, Z., et al. (2021) D-Dimer Level Predicts Angiographic No-Reflow Phenomenon after Percutaneous Coronary Intervention within 2-7 Days of Symptom Onset in Patients with ST-Segment Elevation Myocardial Infarction. Journal of Cardiovascular Translational Research, 14, 728-734. https://doi.org/10.1007/s12265-020-09991-6
|
[43]
|
Mjelva, Ø.R., Pönitz, V., Brügger-Andersen, T., et al. (2016) Long-Term Prognostic Utility of Pentraxin 3 and D-Dimer as Compared to High-Sensitivity C-Reactive Protein and B-Type Natriuretic Peptide in Suspected Acute Coronary Syndrome. European Journal of Preventive Cardiology, 23, 1130-1140. https://doi.org/10.1177/2047487315619733
|
[44]
|
何东明. 血清高敏C反应蛋白和白细胞介素-6水平对冠心病病情评估的价值[J]. 中华实用诊断与治疗杂志, 2012, 26(2): 135-136, 140.
|
[45]
|
Frossard, J.L., Steer, M.L. and Pastor, C.M. (2008) Acute Pancreatitis. The Lancet, 371, 143-152. https://doi.org/10.1016/S0140-6736(08)60107-5
|
[46]
|
Ghanavatian, S., Stein, R.A., Atar, D., et al. (2011) The Course of D-Dimer, High-Sensitivity C-Reactive Protein and Pro-B-Type Natriuretic Peptide in Patients with Non-ST-Elevation Myocardial Infarction. Clinical Laboratory, 57, 771-776.
|
[47]
|
王蓉, 胡东南. D-二聚体和纤维蛋白原的检测在不同类型冠心病诊断中的意义[J]. 中国医药导报, 2006, 3(35): 158 162.
|